Cargando…
Serum adropin as a predictive biomarker of erectile dysfunction in coronary artery disease patients
INTRODUCTION: Erectile dysfunction (ED) is associated with various comorbidities and an early diagnosis and treatment is necessary to avoid the development of these comorbidities. Unfortunately, there is no biochemical marker that can be used for early diagnosis of ED. Nitric oxide (NO) is released...
Autores principales: | Celik, Hüsetin Tugrul, Bilen, Mehmet, Kazancı, Fatmanur, Yildirim, Mehmet Erol, İncebay, İlkay Bekir, Erdamar, Hüsamettin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830486/ https://www.ncbi.nlm.nih.gov/pubmed/31720034 http://dx.doi.org/10.5173/ceju.2019.1666 |
Ejemplares similares
-
The comparison of the influence between two different bowel preparation methods on sepsis after prostate biopsies
por: Yildirim, Mehmet Erol, et al.
Publicado: (2015) -
Adropin and Irisin in Patients with Cardiac Cachexia
por: Kalkan, Ali Kemal, et al.
Publicado: (2018) -
Adropin as a potential marker of enzyme-positive acute coronary syndrome
por: Aydin, Suna, et al.
Publicado: (2017) -
Association between serum adropin levels and isolated coronary artery ectasia in patients with stable angina pectoris
por: Özkan, Buğra, et al.
Publicado: (2019) -
The relationship between radial artery spasm and adropin levels in patients undergoing transradial coronary angiography
por: Bice, Fuat, et al.
Publicado: (2022)